Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 11/02/2025 7:48:26 PM
Board Marks: 394
Posts Today: 5
Board Views Today: 25679
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
KenChowder
07/01/2025 8:38:34 AM
Glad they PRed the CRC survival data. I
(6)
docj
07/01/2025 8:31:15 AM
CytoDyn Announces Encouraging Survival
(3)
Riztheinvestor
07/01/2025 8:30:53 AM
https://www.cytodyn.com/newsroom/press-
(15)
brentie
07/01/2025 7:57:07 AM
"Leading GPCR-targeting therapies
(2)
john1234
07/01/2025 5:36:47 AM
License Information: Menu Entity name:
(1)
john1234
07/01/2025 5:28:22 AM
License Information
(1)
KenChowder
07/01/2025 3:31:25 AM
Yes. Having a DUNS number is beneficial
(1)
mfglola
07/01/2025 12:16:58 AM
I'm thinking, even if we doubled it to
(7)
john1234
06/30/2025 10:05:43 PM
Current ratio for Cydy you can change
(2)
Riztheinvestor
06/30/2025 8:22:08 PM
Bravo!!! Nice find. Impressive find.
(3)
john1234
06/30/2025 7:48:17 PM
A DUNS number is a unique nine-digit ID
(2)
misiu143
06/30/2025 7:39:18 PM
Thank you , look this maybe very
(1)
Riztheinvestor
06/30/2025 7:34:05 PM
John what does this mean?
(1)
Riztheinvestor
06/30/2025 7:33:13 PM
https://colorectalcancer.org/article/pr
(1)
john1234
06/30/2025 7:26:01 PM
From the fda DUNS number for cytodyn
(2)
MGK_2
06/30/2025 7:09:41 PM
Well, taking a look at this chart which
(6)
chazzledazzle
06/30/2025 6:51:06 PM
This is a fine point. There may be
(3)
misiu143
06/30/2025 6:28:04 PM
Yes , but , The new grasshoppers are
(1)
chazzledazzle
06/30/2025 6:25:44 PM
But dont we have something tomorrow?
Ramjet
06/30/2025 6:02:35 PM
For me, I have plenty of reasons to be
(11)
Ramjet
06/30/2025 6:01:25 PM
Charts continue to show non-normal
(8)
Riztheinvestor
06/30/2025 4:33:01 PM
Haha seee lol Thats the hope I might
(1)
misiu143
06/30/2025 4:27:04 PM
Great , so somehow I will see you all
(1)
Riztheinvestor
06/30/2025 4:24:48 PM
Appreciate the advice noted but Im
(1)
misiu143
06/30/2025 4:20:50 PM
I know Riz , we know market is not
(6)
misiu143
06/30/2025 4:11:50 PM
Some removal may happen by mistake ,
(4)
sunray3
06/30/2025 2:48:01 PM
The chart price action has been
(9)
HHIGambler
06/30/2025 1:17:27 PM
I haven't deleted any of your posts
sunray3
06/30/2025 1:09:38 PM
The ORR for TAS-102 and bevacizumab
(4)
Riztheinvestor
06/30/2025 12:52:47 PM
Why are my post about the SEC getting
(3)
HouseofCards
06/30/2025 11:08:45 AM
What kind of ORR do you think we would
(1)
hoops
06/30/2025 8:27:29 AM
T-trade "In finance, a "T-trade" or
hoops
06/30/2025 8:23:52 AM
Looks like a T-trade from Friday. Last
(1)
Boatbuilder
06/30/2025 8:10:35 AM
No OTC stop loss with fidelity. Tried
My69z
06/30/2025 1:06:17 AM
Aug. 12, 2024 & 350mg..... Cytodyn:
(7)
onestepahead
06/29/2025 10:29:54 PM
Very interesting article. Makes more
(9)
KCRoyal2004
06/29/2025 10:11:28 PM
Here, here!!!!! Somebody gets it.....We
(9)
misiu143
06/29/2025 6:54:23 PM
Riz , please read Evil post # 154631 he
(2)
Riztheinvestor
06/29/2025 6:47:52 PM
Sorry clearly Ive been a little busy
(1)
Evil Rabbit
06/29/2025 4:35:46 PM
Now its done and over with lets
(1)
sean007
06/29/2025 4:31:53 PM
Some of these Facts are not
(1)
sean007
06/29/2025 4:26:43 PM
OPSIE...Make that March 9th
(1)
sean007
06/29/2025 4:10:36 PM
Dr. Scott Hansen, PhD to finalize the
(1)
john1234
06/29/2025 4:09:22 PM
June 24, 2025 CytoDyn Announces First
(5)
sean007
06/29/2025 3:43:46 PM
They have known this for well over a
(2)
Ganesha
06/29/2025 2:40:12 PM
" the current focus of CCR5 as an
(8)
SamaGong
06/29/2025 1:36:12 PM
Smoke/mist, Your post refers to "an old
(11)
Hyperbolic
06/29/2025 11:08:41 AM
We have seen hit pieces and negative
(10)
john1234
06/29/2025 9:53:43 AM
CCR5 antagonist, an ally to fight
(5)
john1234
06/29/2025 9:42:36 AM
CCR5 governs DNA damage repair and
(9)
Newer
Older
Recent Articles
Trump's Tariffs Controversy: Why He Stays Away from Court
Savara Inc. Legal Update: What Investors Need to Know
V.F. Corporation Investors Should Be Aware of Class Action
Engwe Unveils Advanced E-Bikes at Major Milan Event
Trump's Unique Views on Cryptocurrency and His Family's Role
Concluding Highlights of the Financial Street Forum 2025 Events
Stock Market Update: Nasdaq Climbs as Earnings Surprise Investors
Stocks to Keep an Eye on This Monday: Key Updates & Insights
Trump's Stance on Nvidia's Blackwell AI Chip and Its Future
2025 Gold Glove Award Winners Announced: Defensive Excellence
Faraday Future Welcomes Chris Nixon Cox as Strategic Advisor
Tronox Holdings Investors Urged to Take Action Before Deadline
How the Surge in AI Usage is Impacting Our Energy Bills
Cryptocurrency Market Update: Key Insights on BTC, ETH, and More
Aquilius Achieves Record-Breaking Fundraising Success
GFM Services Berhad Earns Leadership Recognition for Innovation
AgiBot Pioneers Reinforcement Learning in Robotics Deployment
Aquilius Secures $1.1 Billion for Asia Pacific Real Estate Fund
AgiBot Unveils Milestone in Reinforcement Learning Robotics
Aquilius Secures Unprecedented $1.1 Billion for Real Estate Growth
Exploring the Renaissance of Baijiu: A Global Affair
Nota AI's KOSDAQ Listing Marks a New Era for AI Innovations
Faraday Future Expands Operations with Strategic Partnerships
Bitget and Fasanara Capital Unite for Enhanced Digital Asset Liquidity
WPP plc Investors Urged to Act Before Class Action Deadline
HUTCHMED Showcases Innovative Cancer Treatments at Recent Event
Benitec Biopharma's Latest Update: Advancing Gene Therapy Research
Benitec Biopharma Updates Phase 1b/2a Study for OPMD
HUTCHMED Advances Innovative Cancer Treatments and Pipeline
Join the Movement: Stand Up Against Fraud with Rosen Law
SAMURAI Paint Unveils Innovative Car Spray Paint Series
FireFly Welcomes New Non-Executive Director with Vast Industry Expertise
Dave Ramsey's Critique of Congressional Incompetence
Critical Insights on Savara Inc. and the Upcoming Class Action
FireFly Metals Welcomes Experienced Director to the Team
Discovering Innovations in Vascular Treatments from The VEINS 2025
Lantheus Holdings Class Action: What Investors Need to Know
Unveiling America's Tech Revolution: Buck Sexton's Insights
Alvotech Faces Challenges in Biologics License Approval Process
Alvotech's Progress on FDA Review for AVT05 Biosimilar
Secure Your Rights: Join the Avantor, Inc. Class Action
Latest Updates on Caribou Biosciences' CAR-T Cell Trials
How Tanka's AI Platform is Shaping the Future of Startups
Caribou Biosciences Announces Upcoming Webcast for CAR-T Data
Kevin O'Leary's Journey: Overcoming Failures to Find Freedom
The Secrets Behind A $6.5 Million Used Clothing Business Success
Important Legal Update for Tronox Investors: Act Now
Class Action Alert: Quantum Corporation Stockholder News
Warren Buffett's Reflective Lessons from Investment Mistakes
Transforming Housekeeping into a Lucrative Career Path